The Loneliness of Long-Term Thiopurine Monotherapy for Patients with Inflammatory Bowel Disease
- 7 August 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Digestive Diseases and Sciences
- Vol. 66 (5), 1390-1391
- https://doi.org/10.1007/s10620-020-06512-y
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine MonotherapyDigestive Diseases and Sciences, 2021
- Biomarkers Predictive of Response to Thiopurine Therapy in Inflammatory Bowel DiseaseFrontiers in Medicine, 2020
- Thiopurines in Inflammatory Bowel Disease: New Findings and PerspectivesJournal of Crohn's and Colitis, 2018
- Thiopurines and Methotrexate Use in IBD Patients in a Biologic EraCurrent Treatment Options in Gastroenterology, 2017
- Systematic review with meta‐analysis: mucosal healing is associated with improved long‐term outcomes in Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2015
- Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-TargetAmerican Journal Of Gastroenterology, 2015
- Impact of early thiopurines on surgery in 2770 children and young people diagnosed with inflammatory bowel disease: a national population-based studyAlimentary Pharmacology & Therapeutics, 2015
- Endoscopy Assessment at 1-Year Identifies Long-Term Responders to Thiopurines Maintenance Therapy in Patients With Crohn's DiseaseMedicine, 2015
- Is it Possible to Change Phenotype Progression in Crohn's Disease in the Era of Immunomodulators? Predictive Factors of Phenotype ProgressionAmerican Journal Of Gastroenterology, 2014